Recruiting NCT06392568

Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units

Trial Parameters

Condition Cross Infection

Sponsor Abderrahmane Mami Hospital

Study Type OBSERVATIONAL

Phase N/A

Enrollment 500

Sex ALL

Min Age 18 Years

Max Age N/A

Start Date 2024-04-01

Completion 2024-05-31

All Conditions

Cross Infection Carbapenem Resistant Bacterial Infection Vancomycin-Resistant Enterococcal Infection Critical Illness

Interventions

epidemiological records

Brief Summary

Investigate the epidemiology, risk factors and impact on clinical practice of healthcare-associated infections with emergent highly drug-resistant (eHDR) pathogens, particularly carbapenem resistant enterobacteriaceae and glycopeptides-resistant enterococcus.

Eligibility Criteria

Inclusion Criteria: * Adult ICU patients admitted during the study period Exclusion Criteria: * none

Related Trials

NCT06392568

Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units

View Trial →

NCT04900298

Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygiene System

View Trial →

VIEW ON CLINICALTRIALS.GOV ↗ MORE CROSS INFECTION TRIALS